Labeling Solutions Provider Luminer Expands Extended Content Label Capacity & Capabilities through Infrastructure Investment
Additional high-speed ECL production line broadens bandwidth, offers exacting booklet placement and provides efficiency-based cost effectiveness.
“Introducing our innovative Safe’n’Sound® in 2.25 mL size”: premium add-on and highly customizable passive safety devices adapted to your complex injectable formulations.
The growing prevalence of chronic diseases, along with the evolution of patients’ lifestyles, is driving new ways of administrating parenteral drugs. Novel treatments have become available, with the majority arising from biological molecules. Biologic drugs are predominantly administered via injectable devices, using prefilled syringes as a base. Safe’n’Sound® is a passive, one-handed safety device and is intended to be used by non-experienced users for self-administration as well as by healthcare professionals.
The Safe’n’Sound® needle safety device platform is now available to accommodate 2.25 mL fill volume prefilled syringes. This new 2.25 mL size is specifically relevant to administer complex, high-value drugs such as monoclonal antibodies or other biological therapies. It offers a reliable and intuitive design for user safety, and is compatible with any type of ISO standard 2.25 mL prefilled glass syringe, including various flange types.
Nemera understands the importance of device optimization to increase patient safety during self-administration of medication. Self-administration at home therefore translates into a need for safer, easy-to-use and ergonomic devices. Having patients (or caregivers who are not healthcare professionals) inject a drug brings increased risk of usage errors and needle-stick injuries. Protecting users from sharps injuries, whilst optimizing the injection experience, has become compulsory.
In light of this, the priority is to understand the patient journey in order to provide better outcomes. At the earliest stages of establishing the requirement and user needs for a delivery platform, Nemera works with customers to fully understand the patient journey by using a technique called applied ethnography. This method relies on a combination of interviews and in-context observations of practices, processes and experiences within the patient’s home or natural environment.
Regulations and recommendations are evolving to improve patient and health worker safety. In this context, Nemera’s Safe’n’Sound® product range matches the need for safe and easy-to-use self-deliveries – this passive safety device for prefilled syringes provides increased safety for patients and healthcare professionals.
Plastic at the core of a new circular economy
Through its collaboration with REN Clean Skincare, Aptar and its partners have positioned themselves as pioneers in using material from this revolutionary type of recycled plastic resin supplied by SABIC, a global leader in the production and distribution of polymers and thermoplastic materials. SABIC has perfected the difficult task of converting post-consumer, lowgrade plastic waste otherwise destined for incineration or landfill, into virgin plastic, which has been audited and approved by the ISCC according to a mass balance approach.
Collaboration delivers results for sustainability
The integration of the “regenerated plastic” in the packaging is the result of a novel partnership between Aptar, SABIC and REN Clean Skincare, each responsible for a key link in the value chain.
Experts in airless packaging at Aptar’s plant in Villingen, Germany, were tasked with developing the product’s packaging using SABIC’s new circular certified plastic for all the polypropylene parts. The Villingen site received the ISCC PLUS certification, which guarantees the traceability of the raw material used for packaging injection. It certifies that the material has been used in compliance with ISCC PLUS standards, which ensures a reduction of virgin material use.
Packaged in an eco-designed airless bottle, it is the first global launch in the cosmetic industry to use recycled plastic made of certified circular polymer developed by SABIC, certified by ISCC PLUS and produced by Aptar. This plastic is compliant for use as packaging for both food and cosmetics, and is of a quality that is equal to virgin plastic in terms of visual aspects like transparency, brightness, decorative possibilities and flexibility. The bottle is recyclable at end of life thanks to Aptar’s expertise in singlematerial airless packaging, and has been approved for recyclability by the Technical Committee for the Recycling of Plastic Packaging (COTREP). As a bonus, it has a very high product restitution rate, with practically no loss of the formula.
Aptar, Committed to the circular economy
Aptar is an active member of the World Business Council for Sustainable Development (WBCSD) and the Ellen MacArthur Foundation’s CE100 Network. Aptar has committed to reducing its impact on the planet while creating top quality, sustainable products.
Shelton, Conn.-based Modern began making the shields recently and already is scaling up to production of more than 1 million per day, President Bing Carbone said in a March 23 email to Plastics News.
"I have been affected like everyone else in the world by this coronavirus pandemic," he said. "Rather than sit back and do nothing, we decided we need to do something to help all the men and women on the front lines; the healthcare professionals, first responders and the doctors and nurses, especially right here in the state of Connecticut."
The shields are made of glycol-modified PET. Carbone added that company officials "know that the plastic facemask shields are in dire need and basically unobtainable." As a result, he decided to retrofit Modern's manufacturing facility into large mass-production for the shields.
Modern will remain open during the state shutdown in order to quickly gear up production. Carbone said the firm already has received an order from the state for 500,000 shields. Modern also has received calls from across the country, he added.
The shields are made with all domestically sourced plastic materials.
"This is not a cheap, inferior product and the best news is that it will be made in the USA," Carbone said. "We will be hiring a good deal of unemployed folks right now to help make the masks and fight this pandemic."
He added that the shield masks provide an added layer of protection and are not intended to replace the N-95 masks that are used in health care facilities.
The shields made by Modern also are being made by Laird Plastics, a shapes distributor and fabricator based in Akron, Ohio. Both Modern and Laird are owned by North American Plastics of Irving, Texas.
Modern already has received numerous emails thanking the firm for making the shields, according to Carbone.
"But it's really the first responders, our health care professionals, the doctors and nurses — they're the ones we ought to be thanking," he said. "I literally get goosebumps thinking that in our own way we are helping them and in turn we are helping to squash this virus and get everyone back to somewhat of a normal life sooner than later."
Modern distributes plastic shape products based on engineering resins including sheet, rod, tube and film. The firm also offers custom plastics fabrication. Modern generates about 60 percent of its sales from the medical sector.
Modern Plastics was founded in 1945 by Joseph Carbone, Bing Carbone's grandfather. The firm first did auto glass installation in the 1960s before moving into plastics.
Morchem XPS 2472 A + CS-952 is a high performance Epoxy Silane free aliphatic adhesive designed for retortable aluminium structures. Morchem XPS 2472 is a modular system being also available with Morchem CS-903 addressed to all those applications requiring high chemical resistance without retort processes involved.
Morchem XPS 2472 is part of a complete Epoxy Silane Free product range covering with several grades the most demanding applications: BoV, PET Food, etc.
We would like to thank BOBST for their cooperation during our visit at their Competence Centre in San Giorgio Monferrato.
Container glass reduced by up to 50 percent.
For the first time, the industry is pursuing a common approach: 20 container glass manufacturers have mobilized their resources to successfully implement and finance this pilot project. "We are very proud to announce this joint industry project," comments Feve President Michel Giannuzzi. “Hybrid technology is fundamentally changing the way we produce. With it we can significantly reduce the CO 2 balance in container glass production. This step represents an important milestone for the glass industry in the implementation of our decarbonization strategy. "
Up to 300 t per day in any color
In many of their 150 Europe-wide glassworks, the industry is already working with electrical melting furnaces. However, these melting tanks are small and are used exclusively for the production of white glass from raw materials - recycled glass is hardly ever used. Thanks to the new technology, a glass trough can produce over 300 tons of glass in any color and use large quantities of recycled glass.
The Ardagh Group, the world's second largest manufacturer of container glass, has agreed to build the melting furnace in Germany. Construction will start in 2022 and an evaluation of the first results is planned for 2023. "With this new technology, we are on the way to climate-neutral glass packaging and guarantee long-term sustainable production," explains Martin Peterson, CEO of the Ardagh Group, Glass Europe. "We want to demonstrate the feasibility of electric melting on a commercial scale, which would revolutionize the container glass market."
The "melting furnace of the future" is an extremely ambitious project that requires considerable financial and human resources and a broad spectrum of specialist knowledge. For this reason, the industry has committed to working together. With its sectoral approach, it also wants to secure the support of the European Commission in the form of the ETS Innovation Fund. The project is of central importance, but not the only one the industry is currently dealing with: other approaches to clean production technologies and climate-neutral glass packaging have already been implemented or are being investigated.
about the project
Today, the use of electricity as the main source of energy in the container glass industry is limited to small melting tanks for white glass without the use of recycled glass. The new technologies would remove these restrictions. By replacing 80 percent natural gas with green electricity, the technology reduces the emissions from the melting furnace by 60 percent or around 50 percent of the total CO 2 emissions of a container glassworks.
For the first time ever, the project will bring together leading engineers from 20 container glass manufacturers to demonstrate the feasibility of the concept. With the technology, the industry can use large quantities of recycled glass, which is currently not possible with electric melting tanks. For every additional 10 percent recycled glass that is melted down in the melting furnace, an additional 5 percent in CO 2 emissions and 3 percent in energy consumption can be saved.
Due to its flexibility, the hybrid technology can switch to other energy sources in the event of supply bottlenecks, so that there are no production interruptions. The additional costs (investment and operating costs) of a hybrid melting furnace compared to a conventional melting furnace are estimated to be up to EUR 40 million over the 10-year lifespan of the melting furnace. The main reason for this is the higher electricity costs compared to natural gas (about three times as high per MWh).
Feve is the association of European manufacturers of glass containers for food and beverages, perfume, cosmetics and pharmaceuticals. Its members produce 80 billion glass containers a year. The association has around 60 corporate members from around 20 independent corporate groups. Its 160 production sites are located in 23 European countries and include 125,000 direct and indirect jobs along the entire supply chain.
Valvert only uses already used bottles to produce the new bottle, and no new virgin PET needs to be created. Valvert has been able to secure a reliable supply of the high-quality, food grade rPET that is required for bottled water. This will allow not only the launch of the 100% rPET bottle of 150cl, but also a 50% rPET bottle of 50cl at the same time. The goal is to have the 50cl bottle also made entirely of rPET by the end of 2019.
"We believe the new Valvert 100% rPET bottle is a gamechanger in the next generation of sustainable packaging, stimulating a bottle-to-bottle circular economy", said Emmanuel Gruffat, General Manager of Nestlé Waters Benelux.
The launch of Valvert rPET bottle is an important milestone in Nestlé's innovative approach to tackling packaging waste and commitment to a circular economy.
"At Nestlé we want to take up our responsibility towards our consumers and help shape a more sustainable future", said Michel Mersch, CEO Nestlé Belgilux. "We are determined to look at every option available to help solve the plastic waste challenge and we are embracing multiple solutions that can have an impact now such as developing new materials, improving collection and recycling schemes and driving new behaviors. R&D is in our DNA and we intend to leverage this expertise to serve this goal. We are therefore proud to launch the new Valvert 100% rPET bottle as another milestone in achieving a circular economy and in our journey towards sustainability."
Clinical Trials Summit will brings together Researchers, Doctors, Principle Investigators, Clinical research sites, CROs, CMOs, Investors, and senior executives from Biopharma, Medical devices and Pharmaceutical industries around the globe to discuss, reflect on and develop their ideas. It offers many opportunities for professional contact and development The 11th Annual Clinical Trials Summit 2020 will provide opportunities for everyone to learn, gain insight and new skills, and also, there will be many opportunities to network and meet new peoples from industry and patient’s clinical organizations,Please contact KAVITHA on or Call - +91 44 24762472DELEGATE REGISTRATION:In order to register please contact us on or Call - +91 44 24762472Please note that this is a PAID event and NOT A FREE event (no complimentary passes available). Any invite, email or tickets issued mentioning it as a free pass or free ticket to this event through any third party site will strictly not be accepted by the organizer and entry won’t be granted at the event.Early Bird Discounted Price (Vaild till 14th April 2020) - (INR 10,000 + GST (18%) per delegate) Standard Price (Vaild from 15th April 2020) - (INR 15,000 + GST (18%) per delegate)For Bulk Booking of More Than 5 Delegates – Please let us know your interests.We have more opportunities available for the event, which gives you an opportunity to speak/exhibit/Booth/Stall and create brand awareness. In addition, the networking opportunities in focused and relevant industry gathering provide the personal contact necessary for business development efforts. KEY SPEAKERS:BANOTH VENKATESWARLU, Assistant Drugs Inspector, Central Drug Standard Control Organization (CDSCO)CHIRAG TRIVEDI, Director & Head of Clinical Study Unit, Sanofi-AventisREBU NINAN, Director - Strategic Marketing & Commercial Operations – Biologics, Dr. Reddy’s LaboratoriesPRASANNA GANAPATHI, Associate Vice President – Global Clinical Sciences, Mylan LaboratoriesSHUBHANGI DESAI, Director - Global Clinical Trial Management, Abbott (Singapore)YASMIN SHENOY, Director-Regulatory Affairs, Sanofi-AventisSHREEKANT SAPATNEKAR, Director - Clinical Research, Lilavati Hospital & Research CentreSANDESH SAWANT, Director and Head Clinical Trials, CiplaMURTUZA BUGHEDIWALA, Associate Director – GCO, Johnson & JohnsonRAJENDRA JANI, Senior Subject Expert & Advisor, Clinical Research ConsultantMURUGANANTHAN KRISHNAN, Country Monitoring Head - Global Development Operations, Global Drug Development, NovartisRANJIT BARSHIKAR, CEO - QbD International, United Nations Adviser, Member Editorial Board Journal of Generic Medicines, EnglandSRIRUPA DAS, Director - Medical Affairs, AbbottSUTAPA BANDYOPADHYAY NEOGI, Professor, International Institute of Health Management Research (IIHMR)ANANT PATIL, Asst Professor Department of Pharmacology, Dr DY Patil Medical CollegePRATIKSHA PALAHE, Head NFB, National facility for BiopharmaceuticalsARUN GUPTA, Head Medical Affairs & Clinical Research, Dabur Research & Development CentreJYOTSNA PATWARDHAN, Head Development QA, NovartisVAIBHAV SALVI, Head - Project Management and Strategic Initiatives, Clinical Study Unit, SanofiKARAN THAKKAR, Regional Clinical Site Lead, PfizerPRASHANT A. PANDYA, DGM-Global Strategic Sourcing - Scientific Affairs, Mylan LaboratoriesPRANJAL BORDOLOI, Vice President – Clinical, Medical Affairs & Pharmacovigilance, Veeda Clinical ResearchPRASHANT BODHE, Director, CliniSearchSAKHARAM GARALE, Head South-East Asia Operations ACMA & Managing Partner, RENOVARE Healthcare SolutionsSUJAY KULKARNI, Business Partner/ Medical Expert, NovartisSANDEEP JAGTAP, Assist. General Manager - Clinical R & D, Mylan LaboratoriesPlus many more to join soonGet more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.Date: Thursday, May 28, 2020Location: Kohinoor Continental Hotel
India Warehousing Show is more than India’s leading exhibition on logistics and supply chain: it is the heartbeat of the industry. Bringing the future at your doorsteps, the show brings the industry in its full dimension, gathering all facets of logistics, warehouse infrastructure, material handling, storage, automation and supply chain. The show act as marketplace and driver of innovation and success together creating an ideal platform, positioning your company to the forefront of success. Take the lead with us. Be a part of India Warehousing Show 2020.
COMPACK – Complete Packaging Expo is the professional expo about packaging, Processing Technology, Printing, logistics & warehousing packaging and technologies. it is aimed to raise packaging standards for brands, e-commerce service providers, e-commerce platforms, other packaging & allied accessories.COMAPCK has always been promoted with a view and mission to deliver true value for our esteemed EXHIBITOR. The feedback too has been consistently good and encouraging both from the EXHIBITOR and visitors and that's why COMPACK is truly Premier Packaging Expo!
- INDUSTRY UPDATES
- OUR PRODUCTS
- Our Partners